![]() |
Digital Library |
|
|||||||||||||||||||||||||||
Close | Browse articles from a journal | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||
Details for article 46 of 63 found articles
|
|||||||||||||||||||||||||||||
Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis 1 1 Financial Disclosure: William J. Sandborn, M.D., has received research support from and/or served as a consultant for Procter & Gamble Pharmaceuticals and Salix Pharmaceuticals, and has participated in continuing medical education events sponsored indirectly by Procter & Gamble Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals, Ferring, and Falk Pharma. |
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
Details for article 46 of 63 found articles
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
Koninklijke Bibliotheek - National Library of the Netherlands |